(2-methyl-4-pentyl-1H-indol-3-yl)-naphthalen-1-ylmethanone

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (2-methyl-4-pentyl-1H-indol-3-yl)-naphthalen-1-ylmethanone
• 化学式: C₂₅H₂₅NO
• 分子量: 355.5
• InChiKey: RQECEOXOLSOFPM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.5
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  32.9
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND
  申请人：Novaliq GmbH

  公开号：EP3518921A1

  公开（公告）日：2019-08-07
• [EN] METHODS AND COMPOSITIONS FOR TREATING MUCOSAL TISSUE DISORDERS<br/>[FR] MÉTHODES ET COMPOSITIONS POUR TRAITER DES TROUBLES DU TISSU MUCOSAL
  申请人：UNIV NORTH CAROLINA

  公开号：WO2014070769A1

  公开（公告）日：2014-05-08

  The present invention provides compositions and formulations comprising glutathione with or without thiocyanate and methods of use thereof to treat diseases and disorders in mucosal/epithelial tissue.
• [EN] COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND<br/>[FR] COMPOSITIONS COMPRENANT UN LIGAND DE LIAISON AU RÉCEPTEUR CANNABINOÏDE
  申请人：NOVALIQ GMBH

  公开号：WO2018060282A1

  公开（公告）日：2018-04-05

  The present invention provides a pharmaceutical composition comprising: a) a therapeutically effective amount of at least one cannabinoid receptor binding ligand, and b) a liquid vehicle comprising at least one semifluorinated alkane; as well as the use of such pharmaceutical compositions as a medicament.